Asia Pacific Oxygen Therapy Market Size & Outlook
Asia Pacific oxygen therapy market, 2018-2030 (US$M)
Related Markets
Asia Pacific oxygen therapy market highlights
- The Asia Pacific oxygen therapy market generated a revenue of USD 10,649.8 million in 2022.
- The market is expected to grow at a CAGR of 6.8% from 2023 to 2030.
- In terms of segment, oxygen source equipment was the largest revenue generating product in 2022.
- Oxygen Delivery Devices is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Singapore is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 10,649.8 million |
| Market revenue in 2030 | USD 17,990.1 million |
| Growth rate | 6.8% (CAGR from 2022 to 2030) |
| Largest segment | Oxygen source equipment |
| Fastest growing segment | Oxygen Delivery Devices |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oxygen Source Equipment, Oxygen Delivery Devices |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Inogen Inc, Smiths Group PLC, Fisher & Paykel Healthcare Corp Ltd, Koninklijke Philips NV, Allied Healthcare Products Inc, Teleflex Inc, Chart Industries Inc, Draegerwerk AG & Co KGaA, Niterra Co Ltd, Invacare, Hersill, DeVilbiss Healthcare, Tecno-Gaz |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 30.8% of the global oxygen therapy market in 2022.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 17,990.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oxygen Therapy Market Scope
Oxygen Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific oxygen therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oxygen therapy market will help companies and investors design strategic landscapes.
Oxygen source equipment was the largest segment with a revenue share of 50.52% in 2022. Horizon Databook has segmented the Asia Pacific oxygen therapy market based on oxygen source equipment, oxygen delivery devices covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific accounted for the second-largest revenue share of the global oxygen therapy market. This can be attributed to factors such as increasing rate of hospitalization and rise in COVID-19 cases, which have significantly impelled the demand for oxygen concentrators.
In addition, the demand for medical oxygen concentrators is high not only in ambulatory surgical centers and hospitals but also in home healthcare settings. Owing to this, the oxygen therapy market has been witnessing high growth since the onset of the pandemic.
The Asia Pacific market comprises China, Japan, India, Australia, Singapore, and South Korea. Major players contributing to the market growth in this region by entering into partnerships or expanding their product portfolios are BMC Medical, Lovego, Sterimed Group, and Inogen, Inc.
Reasons to subscribe to Asia Pacific oxygen therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific oxygen therapy market databook
-
Our clientele includes a mix of oxygen therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific oxygen therapy market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific oxygen therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific oxygen therapy market size, by country, 2018-2030 (US$M)
Asia Pacific Oxygen Therapy Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
